Study looks at co-use of CYP2D6-metabolizing opioids, antidepressants in seniors
For older nursing home (NH) residents, use of CYP2D6-metabolized opioids concomitantly with CYP2D6-inhibiting antidepressants is associated with worsening pain and increased risk of opioid-related adverse events (ORAEs), ...
Jul 23, 2024
0
0